Drugs / KJ101
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07025408 | Jun 2025 → Mar 2026 overdue | — | Shanghai Bao Pharmaceuticals Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KJ101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07025408 ↗ |
| Route | Other | “All interventions will be administered locally to the target wound” NCT07025408 ↗ |